Overview
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 30, 2023 | BOTS, Inc. Embarks on Advanced AI Journey With License to Evaluate NVIDIA’s Cutting-Edge Enterprise AI Software | via NewMediaWire – BOTS, Inc. a leading provider of advanced technology solutions, announced that it has obtained a license to evaluate the Artificial Intelligence (AI) software from NVIDIA, a renowned NASDAQ listed public company at the fo... |
| Dec 23, 2022 | Patriot’s Promise Receives $150,000 in Funding Through Vezbi Super App’s Project Seva | California Non-Profit Secures Donation to Support US Veterans. Thanks to Generous Charity Program by Community-Focused Tech Company We are grateful and honored to receive this award from Vezbi’s Project Seva. It will help to maintain our on... |
| Dec 14, 2022 | Boo2Bullying Receives $300,000 in Funding Through Vezbi Super App’s Project Seva | California Non-Profit Secures Donation to Support Programs that Seek to Eradicate Bullying, Thanks to Generous Charity Program by Community-Focused Tech Company We are so grateful to Vezbi’s Project Seva, which is helping us to maintain ong... |
| May 26, 2022 | Flying ice cream? Unilever links with drone delivery service Flytrex | Dive Brief: Unilever has teamed up with drone delivery service Flytrex to deliver ice cream from the CPG giant’s “The Ice Cream Shop” virtual storefront, according to an emailed press release on Wednesday. Shoppers in Flytrex’s coverage are... |
| Jan 20, 2022 | Neovasc : Announces Publication Supporting the Neovasc Reducer Device | VANCOUVER and MINNEAPOLIS - ( NewMediaWire ) - January 20, 2022 - Neovasc, Inc. (Neovasc or the Company) ( NASDAQ , TSX : NVCN) today announced the publication of an article entitled, The Effectiveness of CS Reducer for the Treatment of Ref... |
| Oct 27, 2021 | » Central IRB Approved for ABV-1505 Phase II Part II in Taiwan Sites | ABVC BioPharma Receives Taiwan Regulatory Approval for ABV-1505 ADHD Phase II Part 2 Clinical Study Completion of the Study Expected by the End of 2022 Fremont, CA - (NewMediaWire) - October 27, 2021 - ABVC BioPharma, Inc. (NASDAQ: ABVC), a... |
| Oct 22, 2021 | Neovasc : Reducer Featured in Polish Heart Journal | News Release October 21, 2021 Neovasc Reducer Featured in Polish Heart Journal Publication Highlights Device Success in Chronic Total Occlusions of the Right Coronary Artery VANCOUVER and MINNEAPOLIS - (NewMediaWire) - October 21, 2021 - Ne... |
| Oct 1, 2021 | Timber Pharmaceuticals : Presents at EADV's 30th Anniversary Congress | Basking Ridge, NJ - (NewMediaWire) - October 01, 2021 - Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of trea... |
| Sep 1, 2021 | ABVC BioPharma : » ABVC BioPharma Announces New PCT Filings for MDD and ADHD Treatments | Fremont, CA - (NewMediaWire) - September 01, 2021 - ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS, and ophthalmology, today announced it has file... |
Reviews 0
FAQ about NewMediaWire, Inc.
When was NewMediaWire, Inc. founded?
NewMediaWire, Inc. was founded in 2010.
What has the press written about NewMediaWire, Inc.?
Parsers VC has collected 11 articles mentioning NewMediaWire, Inc., among them “BOTS, Inc. Embarks on Advanced AI Journey With License to Evaluate NVIDIA’s Cutting-Edge Enterprise AI Software” (Nov 30, 2023) and “Patriot’s Promise Receives $150,000 in Funding Through Vezbi Super App’s Project Seva” (Dec 23, 2022).
Is NewMediaWire, Inc. still active?
Yes, NewMediaWire, Inc. is active; its latest activity on Parsers VC dates from Dec 12, 2023.